Literature DB >> 1057669

Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.

P J Bordier, P J Marie, C D Arnaud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1057669

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  6 in total

1.  Trabecular bone morphometry in beagles with chronic renal failure.

Authors:  R W Norrdin; P Bordier; C W Miller
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-09-28

2.  A quantitative histomorphometric comparison of 40 micron thick Paragon sections with 5 micron thick Goldner sections in the study of undecalcified bone.

Authors:  A J Felsenfeld; J M Harrelson; R A Gutman
Journal:  Calcif Tissue Int       Date:  1982-05       Impact factor: 4.333

3.  Defective binding of macrophages to bone in rodent osteomalacia and vitamin D deficiency. In vitro evidence for a cellular defect and altered saccharides in the bone matrix.

Authors:  Z Bar-Shavit; A J Kahn; S L Teitelbaum
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

4.  Short-term effects of vitamin D3 and 1,25-dihydroxyvitamin D3 on osteomalacia in uremic rats fed a low calcium-low-phosphorus diet.

Authors:  S E Weisbrode
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

Review 5.  Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future.

Authors:  Vincent Brandenburg; Markus Ketteler
Journal:  Nutrients       Date:  2022-07-22       Impact factor: 6.706

Review 6.  Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease.

Authors:  Markus Ketteler; Patrice Ambühl
Journal:  J Nephrol       Date:  2021-06-25       Impact factor: 3.902
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.